E1L3N Trademark

Trademark Overview


On Wednesday, April 16, 2014, a trademark application was filed for E1L3N with the United States Patent and Trademark Office. The USPTO has given the E1L3N trademark a serial number of 86254212. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, July 31, 2025. This trademark is owned by Cell Signaling Technology, Inc.. The E1L3N trademark is filed in the Chemical Products category with the following description:

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
e1l3n

General Information


Serial Number86254212
Word MarkE1L3N
Filing DateWednesday, April 16, 2014
Status800 - REGISTERED AND RENEWED
Status DateThursday, July 31, 2025
Registration Number4597348
Registration DateTuesday, September 2, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 17, 2014

Trademark Statements


Pseudo MarkEILEN
Goods and ServicesBiochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, May 1, 2014
Primary Code001
First Use Anywhere DateSaturday, April 5, 2014
First Use In Commerce DateSaturday, April 5, 2014

Trademark Owner History


Party NameCell Signaling Technology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDanvers, MA 01923

Party NameCell Signaling Technology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDanvers, MA 01923

Party NameCell Signaling Technology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDanvers, MA 01923

Trademark Events


Event DateEvent Description
Thursday, May 1, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 19, 2014NEW APPLICATION ENTERED
Friday, May 2, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, May 7, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 28, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 17, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, May 5, 2014ASSIGNED TO EXAMINER
Tuesday, June 17, 2014PUBLISHED FOR OPPOSITION
Tuesday, September 2, 2014REGISTERED-PRINCIPAL REGISTER
Monday, September 2, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 11, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 23, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 23, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 23, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, September 2, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, August 30, 2024TEAS SECTION 8 & 9 RECEIVED
Friday, December 6, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 6, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Tuesday, March 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 6, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, July 31, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, July 31, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, July 31, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED